Your browser doesn't support javascript.
loading
Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells.
Duerr, Claudia U; McCarthy, Connor D A; Mindt, Barbara C; Rubio, Manuel; Meli, Alexandre P; Pothlichet, Julien; Eva, Megan M; Gauchat, Jean-François; Qureshi, Salman T; Mazer, Bruce D; Mossman, Karen L; Malo, Danielle; Gamero, Ana M; Vidal, Silvia M; King, Irah L; Sarfati, Marika; Fritz, Jörg H.
Afiliação
  • Duerr CU; Department of Microbiology and Immunology, Complex Traits Group, McGill University, Montréal, Canada.
  • McCarthy CD; Department of Physiology, Complex Traits Group, McGill University, Montréal, Canada.
  • Mindt BC; Department of Microbiology and Immunology, Complex Traits Group, McGill University, Montréal, Canada.
  • Rubio M; Immunoregulation Laboratories, The Research Center of the Centre Hospitalier de L'Université de Montréal, Montréal, Québec, Canada.
  • Meli AP; Department of Microbiology and Immunology, Microbiome and Disease Tolerance Center, McGill University, Lyman Duff Medical Building, Montréal, Canada.
  • Pothlichet J; Diaccurate, Institut Pasteur, Paris, France.
  • Eva MM; Department of Human Genetics, Complex Traits Group, McGill University, Montréal, Canada.
  • Gauchat JF; Department of Pharmacology, Université de Montréal, Montréal, Canada.
  • Qureshi ST; Meakins Christie Laboratories, McGill University and Department of Critical Care, The Research Institute of the McGill University Health Center, Montréal, Canada.
  • Mazer BD; Department of Pediatrics, McGill University, Meakins Christie Laboratories, The Research Institute of the McGill University Health Center, Montréal, Canada.
  • Mossman KL; Department of Pathology and Molecular Medicine, McMaster Immunology Research Center, Institute for Infectious Disease Research, McMaster University, Hamilton, Canada.
  • Malo D; Department of Human Genetics, Complex Traits Group, McGill University, Montréal, Canada.
  • Gamero AM; Department of Medicine, Complex Traits Group, McGill University, Montréal, Canada.
  • Vidal SM; Department of Medical Genetics and Molecular Biochemistry, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.
  • King IL; Department of Human Genetics, Complex Traits Group, McGill University, Montréal, Canada.
  • Sarfati M; Department of Medicine, Complex Traits Group, McGill University, Montréal, Canada.
  • Fritz JH; Department of Microbiology and Immunology, Microbiome and Disease Tolerance Center, McGill University, Lyman Duff Medical Building, Montréal, Canada.
Nat Immunol ; 17(1): 65-75, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26595887
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Linfócitos / Interferon Tipo I / Imunidade Inata Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções Respiratórias / Linfócitos / Interferon Tipo I / Imunidade Inata Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Canadá